Apollon Wealth Management LLC Buys 1,832 Shares of The Clorox Company (NYSE:CLX)

Apollon Wealth Management LLC raised its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 119.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,364 shares of the company's stock after buying an additional 1,832 shares during the quarter. Apollon Wealth Management LLC's holdings in Clorox were worth $546,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Insight Folios Inc lifted its stake in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock valued at $358,000 after acquiring an additional 63 shares during the last quarter. HCR Wealth Advisors raised its position in shares of Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock worth $1,116,000 after acquiring an additional 68 shares in the last quarter. Empower Advisory Group LLC raised its position in shares of Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company's stock worth $297,000 after acquiring an additional 78 shares in the last quarter. Aviance Capital Partners LLC raised its position in shares of Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company's stock worth $502,000 after acquiring an additional 80 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in shares of Clorox by 9.9% in the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company's stock worth $159,000 after buying an additional 88 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CLX shares. Barclays upped their price target on Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and raised their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. raised their target price on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Wells Fargo & Company raised their target price on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $158.21.

Clorox Price Performance

Shares of Clorox stock traded down $2.86 during trading on Friday, reaching $147.91. 1,318,065 shares of the stock traded hands, compared to its average volume of 1,380,263. The company has a market capitalization of $18.31 billion, a price-to-earnings ratio of 40.41, a P/E/G ratio of 2.52 and a beta of 0.42. The business has a fifty day simple moving average of $159.17 and a two-hundred day simple moving average of $159.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the company earned $2.16 earnings per share. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th were given a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.30%. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.